drugset / Trial / NCT04081597
A Study of Single Ascending Doses of STAR-101 in Healthy Participants
RandomizedCrossoverDouble-blindBasic science
Summary
The study will include a single ascending dose approach to evaluate the safety, tolerability, and pharmacokinetic properties of STAR-101 after a single oral administration in healthy participants
Timeline
- Start
- 2020-02
- Primary completion
- 2020-03
- Completion
- 2020-03
Outcome
Outcome not reported
Stopped (Business): “Change in Clinical Strategy”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Star-101 | Unknown | — | Oral |
Indications
No indication recorded.